The Potential Application of Zoledronic Acid as Anticancer Therapy in Patients with Non-small-cell Lung Cancer

Reshma Mahtani; Raza Khan; Mohammad Jahanzeb

The Potential Application of Zoledronic Acid as Anticancer Therapy in Patients with Non-small-cell Lung Cancer

Reshma Mahtani, Raza Khan, Mohammad Jahanzeb

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Clinical Lung Cancer
Volume	12
State	Published - 2011

Disciplines

Medicine and Health Sciences

Cite this

@article{eeaa879120764b5e8cae75bc3d246a5d,

title = "The Potential Application of Zoledronic Acid as Anticancer Therapy in Patients with Non-small-cell Lung Cancer",

author = "Reshma Mahtani and Raza Khan and Mohammad Jahanzeb",

note = "Non-small-cell lung cancer (NSCLC) is frequently characterized by metastases to bone. Bisphosphonates have demonstrated efficacy in reducing the risk of skeletal-related events in cancer patients with bone metastases, including those with NSCLC. Zoledronic acid (ZA) is one of the most potent bisphos ...",

year = "2011",

language = "American English",

volume = "12",

journal = "Clinical Lung Cancer",

}

TY - JOUR

T1 - The Potential Application of Zoledronic Acid as Anticancer Therapy in Patients with Non-small-cell Lung Cancer

AU - Mahtani, Reshma

AU - Khan, Raza

AU - Jahanzeb, Mohammad

N1 - Non-small-cell lung cancer (NSCLC) is frequently characterized by metastases to bone. Bisphosphonates have demonstrated efficacy in reducing the risk of skeletal-related events in cancer patients with bone metastases, including those with NSCLC. Zoledronic acid (ZA) is one of the most potent bisphos ...

PY - 2011

Y1 - 2011

UR - https://pubmed.ncbi.nlm.nih.gov/21273176/

M3 - Article

VL - 12

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

ER -

The Potential Application of Zoledronic Acid as Anticancer Therapy in Patients with Non-small-cell Lung Cancer

Disciplines

Other files and links

Cite this